Nuvation Bio Inc. (NUVB) has a market capitalization of $1.68B and trades at $4.85. The 52-week range is 1.54-9.75.
Key metrics include a trailing Price-to-Earnings (P/E) ratio of -8.1, Earnings Per Share (EPS) of $-0.60, annual revenue of $62.9M.
The stock has a beta of 1.61, operates in the Healthcare sector.
